Cargando…

CIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells

Poor response and chemotherapy resistance to cisplatin (DDP)-based therapy frequently lead to treatment failure in advanced bladder cancer; however the underlying mechanism is extremely complex and unclear. Furthermore, cancerous inhibitor of protein phosphatase 2A (CIP2A), a recently identified hum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Fengbin, Wang, Xiaojing, Chen, Shanwen, Xu, Tianyuan, Wang, Xianjin, Shen, Yifan, Dong, Fan, Zhong, Shan, Shen, Zhoujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151887/ https://www.ncbi.nlm.nih.gov/pubmed/30106121 http://dx.doi.org/10.3892/or.2018.6641

Ejemplares similares

CIP2A mediates fibronectin-induced bladder cancer cell proliferation by stabilizing β-catenin
por: Gao, Fengbin, et al.
Publicado: (2017)

Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis
por: Dong, Fan, et al.
Publicado: (2018)

Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study
por: Dong, Fan, et al.
Publicado: (2017)

Nomograms to Predict Individual Prognosis of Patients with Primary Small Cell Carcinoma of the Bladder
por: Dong, Fan, et al.
Publicado: (2018)

Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure
por: Dong, Fan, et al.
Publicado: (2017)

Targeting of CCN2 suppresses tumor progression and improves chemo-sensitivity in urothelial bladder cancer
por: Wang, Xiaojing, et al.
Publicado: (2017)

Chloroquine enhances the efficacy of cisplatin by suppressing autophagy in human adrenocortical carcinoma treatment
por: Qin, Liang, et al.
Publicado: (2016)

MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5
por: Xu, Tianyuan, et al.
Publicado: (2016)

Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies
por: Zhu, Zhaowei, et al.
Publicado: (2013)

TIMP-3 Increases the Chemosensitivity of Laryngeal Carcinoma to Cisplatin via Facilitating Mitochondria-Dependent Apoptosis
por: Shen, Xiaohui, et al.
Publicado: (2018)

Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies
por: Zhu, Zhaowei, et al.
Publicado: (2013)

Polyphyllin I and VII potentiate the chemosensitivity of A549/DDP cells to cisplatin by enhancing apoptosis, reversing EMT and suppressing the CIP2A/AKT/mTOR signaling axis
por: Feng, Feifei, et al.
Publicado: (2019)

Specific inhibition of ICAM-1 effectively reduces bladder inflammation in a rat model of severe non-bacterial cystitis
por: Zhang, Xiang, et al.
Publicado: (2016)

p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell
por: Wei, Junxia, et al.
Publicado: (2010)

Inflammatory Pathways as Promising Targets to Increase Chemotherapy Response in Bladder Cancer
por: Zhu, Zhaowei, et al.
Publicado: (2012)

Robotic versus Open Radical Cystectomy: An Updated Systematic Review and Meta-Analysis
por: Xia, Leilei, et al.
Publicado: (2015)

MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin
por: Zhang, Xin, et al.
Publicado: (2015)

The deacetylation of Foxk2 by Sirt1 reduces chemosensitivity to cisplatin
por: Wang, Xi‐wen, et al.
Publicado: (2021)

Cell fate determination in cisplatin resistance and chemosensitization
por: Luong, Khanh V., et al.
Publicado: (2016)

Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells
por: Wang, Qiong, et al.
Publicado: (2010)

Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy
por: Chen, Jinbo, et al.
Publicado: (2016)

Knockdown of HMGN5 increases the chemosensitivity of human urothelial bladder cancer cells to cisplatin by targeting PI3K/Akt signaling
por: Gan, Yu, et al.
Publicado: (2017)

Microarray gene expression analysis of chemosensitivity for docetaxel, cisplatin and 5-fluorouracil (TPF) combined chemotherapeutic regimen in hypopharyngeal squamous cell carcinoma
por: Lian, Meng, et al.
Publicado: (2017)

METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE
por: Li, Ruyi, et al.
Publicado: (2021)

ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer
por: Li, Ching-Chia, et al.
Publicado: (2015)

Chemosensitizing and nephroprotective effect of resveratrol in cisplatin –treated animals
por: Osman, Abdel-Moneim M, et al.
Publicado: (2015)

Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
por: Gąsiorkiewicz, Bartosz Mateusz, et al.
Publicado: (2020)

sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo
por: Ma, Guoliang, et al.
Publicado: (2015)

MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
por: Shen, Hua, et al.
Publicado: (2016)

Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway
por: Li, Hong-Bo, et al.
Publicado: (2021)

Inhibition of secretory leukocyte protease inhibitor (SLPI) promotes the PUMA-mediated apoptosis and chemosensitivity to cisplatin in colorectal cancer cells
por: Wei, Zhijiang, et al.
Publicado: (2023)

Effects of NOB1 on the pathogenesis of osteosarcoma and its expression on the chemosensitivity to cisplatin
por: Luo, Leiming, et al.
Publicado: (2018)

δ-Tocotrienol Induces Human Bladder Cancer Cell Growth Arrest, Apoptosis and Chemosensitization through Inhibition of STAT3 Pathway
por: Ye, Changxiao, et al.
Publicado: (2015)

CIP2A Promotes Proliferation, Invasion and Chemoresistance to Cisplatin in Renal Cell Carcinoma
por: Zhang, Yongzhen, et al.
Publicado: (2018)

PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer
por: Zhu, Haiyan, et al.
Publicado: (2016)

Dacomitinib improves chemosensitivity of cisplatin-resistant human ovarian cancer cells
por: Xu, Lei, et al.
Publicado: (2021)

Loss of AKR1C1 is a good prognostic factor in advanced NPC cases and increases chemosensitivity to cisplatin in NPC cells
por: Zhou, Chen, et al.
Publicado: (2020)

Chemosensitizing activity of peptide from Lentinus squarrosulus (Mont.) on cisplatin-induced apoptosis in human lung cancer cells
por: Khine, Hnin Ei Ei, et al.
Publicado: (2021)

miR-150 Modulates Cisplatin Chemosensitivity and Invasiveness of Muscle-Invasive Bladder Cancer Cells via Targeting PDCD4 In Vitro
por: Lei, Ye, et al.
Publicado: (2014)

Correction to: Chemosensitizing and nephroprotective effect of resveratrol in cisplatin-treated animals
por: Osman, Abdel-Moneim M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ff6v8mbfm5drf01pb98k8imb41